Women's Health 2040
The Vision 2040 Founding Cohort at the Charter launch

Set the vision · Create a roadmap · Own the future

Women's Health 2040

“We're not asking for better health standards for women — we're designing them.”

— Nordic Charter for Women's Health 2040

136+

5

USD 30–50B

3+4+1

Nordic Intelligence Brief

Week of 11 May — 18 May 2026

PCOS is being formally renamed polyendocrine metabolic ovarian syndrome (PMOS) — a Lancet global consensus with Oulu's Terhi Piltonen among the co-authors. The rename lands the same week as a Nordic population study linking the condition to a 32% higher heart disease risk, repositioning PMOS/PCOS as multisystem chronic disease. Finland updates its national Current Care guideline on miscarriage, and Sweden prepares the Medical Products Agency for its EHDS digital health role.

1081 scanned → 59 selected → 22 calls trackedRead this week →

About the Initiative

The Nordic Charter for Women's Health 2040 is a coordination framework developed through participatory strategic foresight with 136+ contributors across five Nordic countries. It positions women's health as economic opportunity — USD 30–50 billion in potential gains — not a cost burden. Published in The Lancet and developed with the Copenhagen Institute for Futures Studies, the Charter enables voluntary alignment across research, care, and innovation without prescribing a single route.

How It Was Built

The Charter initiative was co-led by Julia Persson and Jeanette Kæseler Mortensen, with participatory foresight methodology developed in collaboration with the Copenhagen Institute for Futures Studies and Nordic Women's Health Hub. Over 136 contributors from healthcare, research, policy, and innovation across Denmark, Finland, Iceland, Norway, and Sweden shaped the framework.

The Charter was co-created at the Danish Parliament in September and launched in December 2025 at the Embassy of Finland in Copenhagen, co-hosted by the Nordic Council of Ministers. Watch the launch

The Vision 2040 Founding Cohort at the Charter launch, December 2025

From Charter to Action

The Implementation Playbook publishes 28 May 2026 at BLOX, Copenhagen, on the International Day of Action for Women's Health — mapping Charter activities to existing Nordic and European initiatives. Published as an open commons (CC BY 4.0) in partnership with the Copenhagen Institute for Futures Studies. Ambassadors across the Nordics are carrying the framework into their institutions and networks.

The Women's Health 2040 Framework

Three operational domains. Four infrastructure pillars. One cultural foundation. Independently validated by five expert groups.

The Women's Health 2040 Framework: Research, Care, Innovation across People, Money, Policy, Data with Awareness as foundation

Founding Architect

Julia Persson, Founding Architect

Julia Persson

Founder and CEO of Scita Health, a Danish precision prevention platform for women navigating perimenopause and menopause, and a participating organisation in the WHO/Europe Public Health Innovation Platform. Serves on the EU advisory board for myHealth@myHands. 20+ years of digital transformation experience at Accenture, Swedbank, AWS, and Maersk.

Founding Ambassadors

Five leaders who shaped and champion the Charter across the Nordic region.

Aura Pyykönen

Aura Pyykönen

Independent

🇫🇮 Finland

Christina Lloyd

Christina Lloyd

Care & Communication

🇸🇪 Sweden

Daria Krivonos

Daria Krivonos

Copenhagen Institute for Futures Studies

🇩🇰 Denmark

Hilde Færevik

Hilde Færevik

Innovasjon Norge

🇳🇴 Norway

Kristina Gemzell Danielsson

Kristina Gemzell Danielsson

Karolinska Institutet

🇸🇪 Sweden

In collaboration with

CIFS

Supporting Partners

CMedicalImpact InvestNordic Wellbeing AcademyThémisVILDA SwedenWiLD NorwayWomen’s Health HorizonsCMedicalImpact InvestNordic Wellbeing AcademyThémisVILDA SwedenWiLD NorwayWomen’s Health Horizons

Peer-Reviewed Research

Published in The Lancet

Designing from 2040: vision-led architecture for women's health

Julia Persson · Kristina Gemzell Danielsson · Daria Krivonos

The Lancet Obstetrics, Gynaecology, & Women's Health